Pilot Study of the Effect of Topical Bromfenac Ophthalmic Solution 0.09%in Patients With Acute Post-operative Cystoid Macular Edema.
Johns Hopkins University
This research is being done to look at the effects of Bromfenac, also called Xibrom for the
treatment of swelling in the retina (the light sensitive tissue in the back of the eye)
called "macular edema" that occurs after cataract surgery. Swelling in the retina can lead
to blurry vision.
The most commonly used treatment is eyedrops that decrease inflammation and may help stop
some of the swelling. The investigators want to see if the drug Bromfenac(Xibrom) can
decrease the swelling in the retina after cataract surgery and improve vision in these
Comparing Optical Coherence Tomography (OCT) and Visual Acuity Outcomes in Subjects Undergoing Cataract Surgery, Who Receive Xibrom Ophthalmic Solution and Standard Presurgical Care vs. Xibrom Ophthalmic Solution Plus Prednisolone Acetate 1% and Stan
Bp Consulting, Inc
To compare the efficacy of twice-daily topical bromfenac (Xibrom) ophthalmic solution alone
versus twice-daily topical Xibrom with prednisolone acetate 1% three-times daily on visual
acuity and OCT measurements.
Determination of Optimum Duration of Treatment With Bromfenac (Xibrom) Eyedrops Following Cataract Surgery
Bp Consulting, Inc
The objective of this study is to determine if an extension of bromfenac BID monotherapy is
effective in the decreasing retinal thickening post cataract IOL placement surgery. No
studies exist on how long to treat with an NSAID post cataract IOL placement surgery.
Currently, NSAID therapy post IOL placement surgery is in conjunction with steroid
treatment, lasting approximately 3 weeks. This study is designed to examine if there is
benefit to extending NSAID monotherapy in regards to macular thickening and the incidence of
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.